|
Re: Merge both Zenith and Resverlogic....
|
6
|
Resverlogix Corp.
|
Sep 15, 2015 10:56AM
|
|
Re: Welcome to the RVX Hub - Shon
|
6
|
Resverlogix Corp.
|
Oct 12, 2019 05:50PM
|
|
Re: Up isn't always good...and Down isn't always bad
|
6
|
Resverlogix Corp.
|
Jul 27, 2017 10:54AM
|
|
Re: Zenith Notice of Meeting and Management Information Circular
|
6
|
Resverlogix Corp.
|
Dec 04, 2015 01:48PM
|
|
Re: BETonMACE succeeds.....now what?
|
6
|
Resverlogix Corp.
|
May 29, 2019 02:27PM
|
|
RAAS Inhibitors in Patients with Covid-19
|
6
|
Resverlogix Corp.
|
Mar 31, 2020 07:29AM
|
|
Re: Data Lock - what does it mean for the BoM study and for investors? ...
|
6
|
Resverlogix Corp.
|
Jun 08, 2019 01:59PM
|
|
Re: What if RRR MACE is significant at 90% confidence?
|
6
|
Resverlogix Corp.
|
Apr 23, 2018 10:45PM
|
|
Re: Position Sizing and Odds of Success
|
6
|
Resverlogix Corp.
|
Apr 26, 2019 03:29PM
|
|
Re: CA indication?
|
6
|
Resverlogix Corp.
|
Oct 10, 2019 12:28PM
|
|
Re: Resverlogix H2 2018 events
|
6
|
Resverlogix Corp.
|
Aug 24, 2018 10:15AM
|
|
Re: Age, MoCA and CKD
|
6
|
Resverlogix Corp.
|
Nov 18, 2019 06:00PM
|
|
Re: Futility analysis
|
6
|
Resverlogix Corp.
|
Feb 08, 2017 10:48AM
|
|
Re: ... a full plate..
|
6
|
Resverlogix Corp.
|
Nov 02, 2015 02:05PM
|
|
Re: Bloom Burton - Thoughts, Impressions and quotes....
|
6
|
Resverlogix Corp.
|
May 04, 2018 09:47AM
|
|
New article on BET inhibition and renal disease
|
6
|
Resverlogix Corp.
|
Aug 02, 2016 05:17PM
|
|
A clinical future for RVX-2135 or just a pre-clinical tool
|
6
|
Zenith Epigenetics
|
Aug 11, 2017 01:42PM
|
|
Re: Resverlogix Provides Unrestricted Educational Grant for Epigenetic Symposium at International Renal Congress
|
6
|
Resverlogix Corp.
|
May 25, 2018 10:47AM
|
|
Re: Estimated Glomerular Filtration Rate
|
6
|
Resverlogix Corp.
|
Nov 17, 2019 04:37PM
|
|
Re: I am asking myself....
|
6
|
Resverlogix Corp.
|
Jul 12, 2019 11:05AM
|
